Kombinirovannaya antigipertenzivnaya terapiya v praktike terapevta
- Authors: Drapkina O.M1, Dubolazova Y.V1
-
Affiliations:
- Первый МГМУ им. И.М.Сеченова
- Issue: Vol 13, No 10 (2011)
- Pages: 54-56
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/93467
- ID: 93467
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
O. M Drapkina
Первый МГМУ им. И.М.СеченоваКафедра пропедевтики внутренних болезней
Yu. V Dubolazova
Первый МГМУ им. И.М.СеченоваКафедра пропедевтики внутренних болезней
References
- Рекомендации по лечению артериальной гипертонии Европейского общества гипертонии и европейского общества кардиологов 2007 г.
- Sharma S.K., Ruggenenti P, Remuzzi G. Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination. Vasc Health Risk Manag 2007; 3 (4): 453–65.
- Pepine C.J., Handberg E.M., Cooper-De Hoff R.M. et al.; INVEST Investigators. A calcium antagonist vs a non - calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003; 290 (21): 2805–16.
- Ostergren J, Poulter N.R., Sever P.S. et al.; ASCOT investigators. The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure - lowering limb: effects in patients with type II diabetes. J Hypertens 2008; 26 (11): 2103–11.
- Bangalore S, Messerli F.H., Cohen J.D. et al.; INVEST Investigators. Verapamil - sustained release - based treatment strategy is equivalent to atenolol - based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an International VErapamil SR-Trandolapril (INVEST) substudy. Am Heart J 2008; 156 (2): 241–7.
- Маколкин В.И. Комбинированная терапия артериальной гипертонии: фокус на сочетание антагониста кальция и ингибитора ангиотензин - превращающего фермента. www.medi.ru
- Арутюнов Г.П. Гипотензивная терапия у курящих пациентов: выбор кардиолога. www.health-ua.com
- Арутюнов Г.П., Кобалава Ж.Д., Карпов Ю.А. и др. Двойное открытое параллельное исследование по изучению влияния Квинаприла в сравнении с Лизиноприлом на дисфункцию эндотелия у курящих пациентов, страдающих мягкой и умеренной артериальной гипертензией в сочетании со стенокардией и имеющих микроальбуминурию. Сердце. 2007; 6 (4).
- Butler R, Morris A.D., Struthers A.D. Lisinopril improves endothelial function in chronic cigarette smokers. Clin Sci (Lond) 2001; 101 (1): 53–8.
- Hornig B, Arakawa N, Drexler H. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure. Eur Heart J 1998; 19 (Suppl. G): G48–53.
- www.euro.who.int/obesity
- Haftenberger M et al. Overweight, obesity and fat distribution in 50- to 64 - year - old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutrition 2002; 5: 1147–62.
- Kim M.H. Prevalence of the Metabolic Syndrome and its Association with Cardiovascular Diseases in Korea. J Korean Med Sci 2004; 19: 195–201.
- Bakris G, Molitch M, Hewkin A et al.; STAR Investigators. Differences in glucose tolerance between fixed - dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care 2006; 29 (12): 2592–7.
- Widimsky J. The fixed combination of verapamil SR/trandolapril. Expert Opin Pharmacother 2000; 1 (3): 515–35.
- Ruggenenti P, Fassi A, Parvanova - Ilieva A et al. for the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators. Preventing Microalbuminuria in Type 2 Diabetes. NEJM 2004; 351 (19): 1941–51.
- Nakou E, Filippatos T.D., Liberopoulos E.N. et al. Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients. Expert Opin Pharmacother 2008; 9 (10):1629–39.
- Widimsky J. The fixed combination of verapamil SR/trandolapril. Expert Opin Pharmacother 2000; 1 (3): 515–35.
- Karlberg B.E., Andrup M, Oden A. Efficacy and safety of a new long - acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists. Blood Press 2000; 9 (2–3): 140–5.
- Rubio-Guerra A.F., Lozano-Nuevo J.J., Vargas-Ayala G et al. Efficacy of a fixed - dose combination of trandolapril - verapamil in obese hypertensive patients resistant to monotherapy. Clin Exp Hypertens 2006; 28 (7): 619–24.
Supplementary files
